StarZero All shows Try the podcast clipper →

May 29, 2025 · 25m · no-priors

No Priors Ep. 116 | With Sarah and Elad

Elad Gil · 14m spoken Sarah Guo · 8m spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In this episode of No Priors, hosts Sarah Guo and Elad Gil analyze market consolidation and merger strategies in AI, untapped commercial frontiers in longevity biotechnology, and the technical roadmaps toward agentic intelligence and neuromodulation.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. The hosts hold 99.9% of the talking time here. How this is scored →

The hosts as informed peer 7.2 Guest teaching 1.6 Guest disagreement 1.0 The hosts pushing back 1.0
05100:0010:0020:000:01–6:05 · The hosts as informed peer 7/10 AI Market Consolidation and Vertical Application Leaders Elad and Sarah engage in an analytical, peer-level exchange breaking down vertical market consolidation across healthcare, coding, customer success, and sales tooling.6:06–10:08 · The hosts as informed peer 8/10 Startup M&A Dynamics and Founder Merge Strategies Elad shares strategic M&A playbooks from his Twitter operating days and historical examples like PayPal/X.com, while Sarah adds perspective on investor psychology and relative valuation metrics.10:09–17:10 · The hosts as informed peer 8/10 Unrealized Commercial Opportunities in Biotechnology and Longevity Elad delivers a deep technical monologue on overlooked commercial biology opportunities in fertility, oocytes, tooth regrowth, and the structural VC funding failure in biopharma.17:10–22:57 · The hosts as informed peer 7/10 World Models, Reinforcement Learning, and Agentic Intelligence Sarah outlines the limitations of behavioral cloning in agentic AI workflows and explains reinforcement learning in world models, while Elad draws analogies to unconstrained search in Go and molecular evolution.22:57–24:45 · The hosts as informed peer 6/10 Transhumanism, Sci-Fi Narratives, and Neuromodulation Horizons The conversation shifts to speculative transhumanism and sci-fi concepts, where Sarah lightly reframes Elad's upload theory by pointing out near-term ultrasound neuromodulation technology.0:01–6:05 · Guest teaching 1/10 AI Market Consolidation and Vertical Application Leaders Elad and Sarah engage in an analytical, peer-level exchange breaking down vertical market consolidation across healthcare, coding, customer success, and sales tooling.6:06–10:08 · Guest teaching 1/10 Startup M&A Dynamics and Founder Merge Strategies Elad shares strategic M&A playbooks from his Twitter operating days and historical examples like PayPal/X.com, while Sarah adds perspective on investor psychology and relative valuation metrics.10:09–17:10 · Guest teaching 2/10 Unrealized Commercial Opportunities in Biotechnology and Longevity Elad delivers a deep technical monologue on overlooked commercial biology opportunities in fertility, oocytes, tooth regrowth, and the structural VC funding failure in biopharma.17:10–22:57 · Guest teaching 2/10 World Models, Reinforcement Learning, and Agentic Intelligence Sarah outlines the limitations of behavioral cloning in agentic AI workflows and explains reinforcement learning in world models, while Elad draws analogies to unconstrained search in Go and molecular evolution.22:57–24:45 · Guest teaching 2/10 Transhumanism, Sci-Fi Narratives, and Neuromodulation Horizons The conversation shifts to speculative transhumanism and sci-fi concepts, where Sarah lightly reframes Elad's upload theory by pointing out near-term ultrasound neuromodulation technology.0:01–6:05 · Guest disagreement 1/10 AI Market Consolidation and Vertical Application Leaders Elad and Sarah engage in an analytical, peer-level exchange breaking down vertical market consolidation across healthcare, coding, customer success, and sales tooling.6:06–10:08 · Guest disagreement 1/10 Startup M&A Dynamics and Founder Merge Strategies Elad shares strategic M&A playbooks from his Twitter operating days and historical examples like PayPal/X.com, while Sarah adds perspective on investor psychology and relative valuation metrics.10:09–17:10 · Guest disagreement 1/10 Unrealized Commercial Opportunities in Biotechnology and Longevity Elad delivers a deep technical monologue on overlooked commercial biology opportunities in fertility, oocytes, tooth regrowth, and the structural VC funding failure in biopharma.17:10–22:57 · Guest disagreement 1/10 World Models, Reinforcement Learning, and Agentic Intelligence Sarah outlines the limitations of behavioral cloning in agentic AI workflows and explains reinforcement learning in world models, while Elad draws analogies to unconstrained search in Go and molecular evolution.22:57–24:45 · Guest disagreement 1/10 Transhumanism, Sci-Fi Narratives, and Neuromodulation Horizons The conversation shifts to speculative transhumanism and sci-fi concepts, where Sarah lightly reframes Elad's upload theory by pointing out near-term ultrasound neuromodulation technology.0:01–6:05 · The hosts pushing back 1/10 AI Market Consolidation and Vertical Application Leaders Elad and Sarah engage in an analytical, peer-level exchange breaking down vertical market consolidation across healthcare, coding, customer success, and sales tooling.6:06–10:08 · The hosts pushing back 1/10 Startup M&A Dynamics and Founder Merge Strategies Elad shares strategic M&A playbooks from his Twitter operating days and historical examples like PayPal/X.com, while Sarah adds perspective on investor psychology and relative valuation metrics.10:09–17:10 · The hosts pushing back 1/10 Unrealized Commercial Opportunities in Biotechnology and Longevity Elad delivers a deep technical monologue on overlooked commercial biology opportunities in fertility, oocytes, tooth regrowth, and the structural VC funding failure in biopharma.17:10–22:57 · The hosts pushing back 1/10 World Models, Reinforcement Learning, and Agentic Intelligence Sarah outlines the limitations of behavioral cloning in agentic AI workflows and explains reinforcement learning in world models, while Elad draws analogies to unconstrained search in Go and molecular evolution.22:57–24:45 · The hosts pushing back 1/10 Transhumanism, Sci-Fi Narratives, and Neuromodulation Horizons The conversation shifts to speculative transhumanism and sci-fi concepts, where Sarah lightly reframes Elad's upload theory by pointing out near-term ultrasound neuromodulation technology.

speaking balance: gold is the hosts, purple is the guest (3 minute bins)

0:00 · the hosts 99.8% · guest 0.2%0:00 · the hosts 99.8% · guest 0.2%3:00 · the hosts 99.7% · guest 0.3%3:00 · the hosts 99.7% · guest 0.3%6:00 · the hosts 99.8% · guest 0.2%6:00 · the hosts 99.8% · guest 0.2%9:00 · the hosts 100% · guest 0%9:00 · the hosts 100% · guest 0%12:00 · the hosts 100% · guest 0%12:00 · the hosts 100% · guest 0%15:00 · the hosts 100% · guest 0%15:00 · the hosts 100% · guest 0%18:00 · the hosts 100% · guest 0%18:00 · the hosts 100% · guest 0%21:00 · the hosts 100% · guest 0%21:00 · the hosts 100% · guest 0%24:00 · the hosts 100% · guest 0%24:00 · the hosts 100% · guest 0%
Sharpest disagreement ▶ 12:08 Elon Musk reproduction thought experiment

Sarah playfully pushes back with alarm on the non-consensual genetic reproduction ramifications of cellular reprogramming.

 Hardest push from the hosts ▶ 22:49 Ultrasound neuromodulation counterpoint

Sarah counters Elad's digital mind upload framing by pointing out that non-invasive ultrasound devices can modulate emotional states without requiring transhuman uploads.

 Biggest teaching moment ▶ 14:32 Biopharma fund structure and acquisition model breakdown

Elad educates on why modern biotech VCs build companies exclusively for pharma pipeline flips rather than building de novo standalone giants.

 The host holds their own ▶ 7:05 Twitter acquisition formula and pragmatic M&A strategy

Elad demonstrates seasoned dealmaking expertise by detailing the pragmatic user-ratio valuation methodology he executed while leading corporate development at Twitter.
the scores for every segment, with the reasoning behind each
ChapterTopicThe hosts as informed peerGuest teachingGuest disagreementThe hosts pushing backWhy
AI Market Consolidation and Vertical Application Leaders 7111 Elad and Sarah engage in an analytical, peer-level exchange breaking down vertical market consolidation across healthcare, coding, customer success, and sales tooling.
Startup M&A Dynamics and Founder Merge Strategies 8111 Elad shares strategic M&A playbooks from his Twitter operating days and historical examples like PayPal/X.com, while Sarah adds perspective on investor psychology and relative valuation metrics.
Unrealized Commercial Opportunities in Biotechnology and Longevity 8211 Elad delivers a deep technical monologue on overlooked commercial biology opportunities in fertility, oocytes, tooth regrowth, and the structural VC funding failure in biopharma.
World Models, Reinforcement Learning, and Agentic Intelligence 7211 Sarah outlines the limitations of behavioral cloning in agentic AI workflows and explains reinforcement learning in world models, while Elad draws analogies to unconstrained search in Go and molecular evolution.
Transhumanism, Sci-Fi Narratives, and Neuromodulation Horizons 6211 The conversation shifts to speculative transhumanism and sci-fi concepts, where Sarah lightly reframes Elad's upload theory by pointing out near-term ultrasound neuromodulation technology.

Statements from this episode (9)

Opinion
Gil: AI coding market has consolidated into a few key players
“Encoding, it seems like it's consolidated into two or three players. You know, maybe that's Cursor, Codium, Cognition, and then Microsoft, Microsoft's like Copilot, right? But there aren't probably like two dozen companies that are all still competing there.”
Elad Gil May 29, 2025 ▶ 1:15
Opinion
Gil: AI customer success is consolidating around Sierra and Decagon
“In customer success, it seems like things are kind of consolidating against Sierra and Decagon.”
Elad Gil May 29, 2025 ▶ 1:30
Insight
Gil: Top startups should merge to fight incumbents instead of each other
“If I was a number one or number two in a market and I was a startup, I'd consider merging with the other party if there were the two main startup players, because the real threat will be fighting the incumbents.”
Elad Gil May 29, 2025 ▶ 6:20
Disclosure
Gil: Twitter tried to acquire a social network using strictly user ratios
“Years ago when I was at Twitter I drove an attempt to buy a major social network that was up and coming. And the way we constructed that offer is we just took their users and our users, added them up and then divided the ratio and made that offer as a proporti…”
Elad Gil May 29, 2025 ▶ 7:54
Assertion Contradicted
Gil: No $50B+ biotech started since the 1980s, excluding Moderna
“The last time a fifty billion dollar plus biotech company was started from scratch, excluding Moderna, which was kind of an accident of COVID, was in the eighties. I think it was Regeneron. And so it's been almost 40 years since we've had a de novo, like tens …”
Elad Gil May 29, 2025 ▶ 14:45
Insight
Gil: Biotech VC incubations are designed to flip to pharma pipelines
“A lot of the companies are started as incubations by biotech VCs. So they load up a company with forty million dollars. They buy 40% of it upfront, whatever it is. And then they kind of have to make it far enough that they can get almost public market money ef…”
Elad Gil May 29, 2025 ▶ 15:36
Assertion Not checkable as stated
Guo: Behavior cloning for AI agents remains brittle on out-of-distribution tasks
“My understanding is that the labs have spent, some labs more than others, right have spent a lot of money collecting traces of humans doing sophisticated tasks. Like, this is how Elad looks at Japanese stem cell differentiation research, right? He does these t…”
Sarah Guo May 29, 2025 ▶ 18:48
Opinion
Guo: Near-term commercial uses of world models are uninteresting
“I actually don't know that I believe that any of the sort of more immediate term commercial applications of these models are interesting. People are like, oh, we can generate games or we'll have like gaming assets or we'll use the data for robotics training or…”
Sarah Guo May 29, 2025 ▶ 21:14
Prediction Not checkable as stated
Guo: Consumer ultrasound devices will soon modulate human emotion and attention
“I'm told that the modulation of emotions and attention actually doesn't require upload. Like Fred and some professors we know would say it's just ultrasound devices coming soon to, you know, a consumer shelf near you”
Sarah Guo May 29, 2025 ▶ 24:29
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more